ATRS Antares Pharma Inc

Antares Pharma Inc is a specialty pharmaceutical company. It is engaged in developing and commercializing self-administered parenteral pharmaceutical products and technologies including novel, pressure-assisted injectors.

$5.59  0.00 (0.00%)
As of 05/23/2022 00:00:00 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Medical Instruments & Supplies
Index country:  USA
Country of incorporation:  USA
IPO date:  06/11/2012
Outstanding shares:  170,852,427
Average volume:  2,705,014
Market cap:   $953,354,176
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      2383163

---

Valuation   (See tab for details)

---

PE ratio:   23.77
PB ratio:   5.43
PS ratio:   5.20
Return on equity:   24.16%
Net income %:   23.15%